병용금기: 두 개 이상의 약물을 같이 투여했을 때 예상하지 못한 이상반응이 나타나거나 치료효과의 상실을 초래하는 약물.
  
검색결과: 총 606개 중 41 - 60

페리돌정5mg(할로페리돌)의 병용금기에 해당되는 제품

제품명▼성분명주성분코드표준코드판매사고시번호적용일
티세르신정100밀리그램(레보메프로마진말레산염)_(0.1353g/1정)levomepromazine maleate (as levomepromazine)183301ATB651902180명인제약(주)2019013120191217
트리레보정75/18.75/200mg_(1정)carbidopa monohydrate (as carbidopa)507200ATB651904240명인제약(주)2019013120191217
트리레보정75/18.75/200mg_(1정)entacapone507200ATB651904240명인제약(주)2019013120191217
트리레보정75/18.75/200mg_(1정)levodopa507200ATB651904240명인제약(주)2019013120191217
트리레보정50/12.5/200mg_(1정)carbidopa monohydrate (as carbidopa)468400ATB651904250명인제약(주)2019013120191217
트리레보정50/12.5/200mg_(1정)entacapone468400ATB651904250명인제약(주)2019013120191217
트리레보정50/12.5/200mg_(1정)levodopa468400ATB651904250명인제약(주)2019013120191217
트리레보정200/50/200mg_(1정)carbidopa monohydrate (as carbidopa)499900ATB651904480명인제약(주)2019013120191217
트리레보정200/50/200mg_(1정)entacapone499900ATB651904480명인제약(주)2019013120191217
트리레보정200/50/200mg_(1정)levodopa499900ATB651904480명인제약(주)2019013120191217
트리레보정150/37.5/200mg_(1정)carbidopa monohydrate (as carbidopa)468900ATB651904490명인제약(주)2019013120191217
트리레보정150/37.5/200mg_(1정)entacapone468900ATB651904490명인제약(주)2019013120191217
트리레보정150/37.5/200mg_(1정)levodopa468900ATB651904490명인제약(주)2019013120191217
트리레보정125/31.25/200mg_(1정)carbidopa monohydrate (as carbidopa)507300ATB651904180명인제약(주)2019013120191217
트리레보정125/31.25/200mg_(1정)entacapone507300ATB651904180명인제약(주)2019013120191217
트리레보정125/31.25/200mg_(1정)levodopa507300ATB651904180명인제약(주)2019013120191217
트리레보정100/25/200mg_(1정)carbidopa monohydrate (as carbidopa)468300ATB651904200명인제약(주)2019013120191217
트리레보정100/25/200mg_(1정)entacapone468300ATB651904200명인제약(주)2019013120191217
트리레보정100/25/200mg_(1정)levodopa468300ATB651904200명인제약(주)2019013120191217
트리도파정75/18.75/200밀리그램_(1정)carbidopa monohydrate (as carbidopa)507200ATB645404520제일약품(주)2019013120191217